CCM therapy is now indicated for symptomatic heart failure patients with diastolic or systolic ventricular dysfunction, ...

Impairment of left ventricular (LV) diastolic function as well as systolic function appear very early in the course of heart disease. Recent HF guidelines, therefore, place special emphasis on the ...

Diastolic heart failure is defined clinically when signs and symptoms of heart failure are present in the presence of preserved left ventricular systolic function (ejection fraction >45%).

A gene therapy for heart failure with preserved ejection fraction (HFpEF), also known as diastolic heart failure, has shown ...

A new study uncovers compelling evidence that even subtle heart issues may affect brain structure — potentially years before ...

CCM therapy is now indicated for symptomatic heart failure patients with diastolic or systolic ventricular dysfunction, offering a broader range of patients a new option for improving quality of life ...

People who have early signs of heart problems may also have changes in brain health that can be early signs of dementia, such ...

In Europe, the OPTIMIZER Smart Mini system is indicated for use in patients who are older than 18 years of age with symptomatic heart failure due to systolic and diastolic left ventricular ...

Changes in the heart might mean more than just cardiovascular risk – they could also signal early shifts in brain health. A ...

LV filling pressures increase during dynamic exercise in association with inadequate enhancement of relaxation and acute increases in LV chamber stiffness. Therapies that enhance diastolic reserve ...

The EuroHeart Failure survey programme-a survey on the quality of care among patients with heart failure in Europe: Part 1: patient characteristics and diagnosis. European heart journal , 24 (5 ...